Abstract

Magnesium levels in cardiac myocytes change in cardiovascular diseases. Intracellular free magnesium (Mgi) inhibits L-type Ca2+ currents through CaV1.2 channels in cardiac myocytes, but the mechanism of this effect is unknown. We hypothesized that Mgi acts through the COOH-terminal EF-hand of CaV1.2. EF-hand mutants were engineered to have either decreased (D1546A/N/S/K) or increased (K1543D and K1539D) Mg2+ affinity. In whole-cell patch clamp experiments, increased Mgi reduced both Ba2+ and Ca2+ currents conducted by wild type (WT) CaV1.2 channels expressed in tsA-201 cells with similar affinity. Exposure of WT CaV1.2 to lower Mgi (0.26 mM) increased the amplitudes of Ba2+ currents 2.6 ± 0.4–fold without effects on the voltage dependence of activation and inactivation. In contrast, increasing Mgi to 2.4 or 7.2 mM reduced current amplitude to 0.5 ± 0.1 and 0.26 ± 0.05 of the control level at 0.8 mM Mgi. The effects of Mgi on peak Ba2+ currents were approximately fit by a single binding site model with an apparent Kd of 0.65 mM. The apparent Kd for this effect of Mgi was shifted ∼3.3- to 16.5-fold to higher concentration in D1546A/N/S mutants, with only small effects on the voltage dependence of activation and inactivation. Moreover, mutant D1546K was insensitive to Mgi up to 7.2 mM. In contrast to these results, peak Ba2+ currents through the K1543D mutant were inhibited by lower concentrations of Mgi compared with WT, consistent with approximately fourfold reduction in apparent Kd for Mgi, and inhibition of mutant K1539D by Mgi was also increased comparably. In addition to these effects, voltage-dependent inactivation of K1543D and K1539D was incomplete at positive membrane potentials when Mgi was reduced to 0.26 or 0.1 mM, respectively. These results support a novel mechanism linking the COOH-terminal EF-hand with modulation of CaV1.2 channels by Mgi. Our findings expand the repertoire of modulatory interactions taking place at the COOH terminus of CaV1.2 channels, and reveal a potentially important role of Mgi binding to the COOH-terminal EF-hand in regulating Ca2+ influx in physiological and pathophysiological states.

Highlights

  • Magnesium is the second most abundant intracellular cation (Elin, 1994)

  • Cardiovascular diseases are associated with alterations in Ca2ϩ homeostasis (Tomaselli and Marban, 1999), and Mgi can modulate multiple proteins involved in Ca2ϩ transport (White and Hartzell, 1988, 1989; Hartzell and White, 1989; Xu et al, 1996; Wei et al, 2002), including substantial effects on the L-type Ca2ϩ current density, inactivation, and voltage dependence (White and Hartzell, 1988; Agus et al, 1989; Kuo and Hess, 1993; Yamaoka and Seyama, 1996; Pelzer et al, 2001; Wang et al, 2004)

  • Modulation of CaV1.2 Channels by Intracellular Mg2ϩ To determine whether Mgi modulates cloned CaV1.2 channels expressed in tsA-201 cells, we examined the electrophysiological properties of wild type (WT) CaV1.2 channels over a range of intracellular Mgi concentrations from 0.1 to 7.2 mM

Read more

Summary

Introduction

Magnesium is the second most abundant intracellular cation (Elin, 1994). In the heart, the level of free intracellular magnesium (Mgi) is well controlled but alterations are observed in a variety of cardiovascular diseases (Murphy, 2000). Cardiovascular diseases are associated with alterations in Ca2ϩ homeostasis (Tomaselli and Marban, 1999), and Mgi can modulate multiple proteins involved in Ca2ϩ transport (White and Hartzell, 1988, 1989; Hartzell and White, 1989; Xu et al, 1996; Wei et al, 2002), including substantial effects on the L-type Ca2ϩ current density, inactivation, and voltage dependence (White and Hartzell, 1988; Agus et al, 1989; Kuo and Hess, 1993; Yamaoka and Seyama, 1996; Pelzer et al, 2001; Wang et al, 2004). It has been proposed that Mgi could produce its effects directly by interacting with the Ca2ϩ channel protein (Kuo and Hess, 1993; Yamaoka and Seyama, 1996) or indirectly by altering enzyme activities that require Mgi as a cofactor or regulator, such as protein kinases or phosphoprotein phosphatases (Pelzer et al, 2001)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call